These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11749887)

  • 41. Investigation of the functional variant c.-169T > C of the Fc receptor-like 3 (FCRL3) gene in alopecia areata.
    Schäfer N; Blaumeiser B; Becker T; Freudenberg-Hua Y; Hanneken S; Eigelshoven S; Schmael C; Lambert J; De Weert J; Kruse R; Nöthen MM; Betz RC
    Int J Immunogenet; 2006 Dec; 33(6):393-5. PubMed ID: 17117947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy.
    Hubiche T; Léauté-Labrèze C; Taïeb A; Boralevi F
    Br J Dermatol; 2008 May; 158(5):1136-7. PubMed ID: 18279461
    [No Abstract]   [Full Text] [Related]  

  • 43. Alopecia areata: genetic complexity underlies clinical heterogeneity.
    Dudda-Subramanya R; Alexis AF; Siu K; Sinha AA
    Eur J Dermatol; 2007; 17(5):367-74. PubMed ID: 17673378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes.
    Feletti F; Vincenzi C; Pazzaglia M; Tosti A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):421-3. PubMed ID: 17309487
    [No Abstract]   [Full Text] [Related]  

  • 45. Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
    Ujiie H; Sawamura D; Shibaki A; Shimizu H
    Clin Exp Dermatol; 2005 Sep; 30(5):579-80. PubMed ID: 16045698
    [No Abstract]   [Full Text] [Related]  

  • 46. Cutaneous latanoprost in the treatment of alopecia areata.
    Mehta JS; Raman J; Gupta N; Thoung D
    Eye (Lond); 2003 Apr; 17(3):444-6. PubMed ID: 12724722
    [No Abstract]   [Full Text] [Related]  

  • 47. Alopecia areata in Down syndrome: a clinical evaluation.
    Schepis C; Barone C; Lazzaro Danzuso GC; Romano C
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):769-70. PubMed ID: 16268894
    [No Abstract]   [Full Text] [Related]  

  • 48. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic approach to alopecia areata.
    Wiseman MC; Shapiro J
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S31-5. PubMed ID: 11749888
    [No Abstract]   [Full Text] [Related]  

  • 50. EEG findings, rapid ACTH test and autonomic nervous symptoms in patients with alopecia areata.
    Ishizaki F; Sasaki K; Shimoda Y; Shimao S
    J Neural Transm; 1976; 38(1):71-5. PubMed ID: 177733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Turning grey overnight, is it possible?].
    Erwteman TM; Evers R
    Ned Tijdschr Geneeskd; 1993 Aug; 137(32):1628. PubMed ID: 8366969
    [No Abstract]   [Full Text] [Related]  

  • 52. Probing the effects of stress mediators on the human hair follicle: substance P holds central position.
    Peters EM; Liotiri S; Bodó E; Hagen E; Bíró T; Arck PC; Paus R
    Am J Pathol; 2007 Dec; 171(6):1872-86. PubMed ID: 18055548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alopecia in women.
    Thiedke CC
    Am Fam Physician; 2003 Mar; 67(5):1007-14. PubMed ID: 12643360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel therapies for alopecia areata: The era of rational drug development.
    Wang ECE; Dai Z; Christiano AM
    J Allergy Clin Immunol; 2018 Feb; 141(2):499-504. PubMed ID: 29155099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alopecia areatia: pathophysiology and latest developments.
    Hordinsky MK
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S28-30. PubMed ID: 11749887
    [No Abstract]   [Full Text] [Related]  

  • 56. Alopecia areata: the need for guidelines and evidence-based dermatology.
    Sladden MJ; MacDonald Hull SP; Wood ML; Hutchinson PE; Messenger AG
    Br J Dermatol; 2005 May; 152(5):1086-7. PubMed ID: 15888188
    [No Abstract]   [Full Text] [Related]  

  • 57. An update on alopecia areata.
    Kos L; Conlon J
    Curr Opin Pediatr; 2009 Aug; 21(4):475-80. PubMed ID: 19502982
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.